Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NT-I7 (efineptakin alfa) in combination with pembrolizumab in adults with advanced solid tumors has completed and…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer [Phase 1]
This update indicates the Phase 1b trial combining LDE225 (sonidegib) with paclitaxel in recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Biobehavioral-Cytokine Interactions in Ovarian Cancer
This completed clinical trial investigated the interactions between biobehavioral factors and cytokine signaling in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Acupressure for Fatigue in Ovarian Cancer Survivors [NA]
The University of Michigan Rogel Cancer Center completed a clinical trial evaluating acupressure to relieve fatigue in ovarian cancer surviv…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer [EARLY_Phase 1]
An early-phase 1 clinical trial assessed whether statin therapy could slow progression in women with platinum-sensitive ovarian cancer. The …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer
Real-world data assess the effectiveness and safety of niraparib in Korean women with primary and recurrent epithelial ovarian cancer. The s…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating SON-1010 in combination with atezolizumab for platinum-resistant ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Phase I Trial of VS-6766 Alone and in Combination With Everolimus [Phase 1]
Completed Phase I trial evaluating VS-6766 alone and in combination with everolimus in patients with solid tumors, multiple myeloma, lung ca…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Performance Study of (Opportunistic) Salpingectomy [NA]
This document notes the completion of a clinical trial evaluating opportunistic salpingectomy as a surgical approach for patients with adnex…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study of PHN-010 in Patients With Advanced Solid Tumors [Phase 1]
PHN-010 Phase 1 trial in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial update for HER3-DXd in locally advanced or metastatic solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating telmisartan in combination with cytotoxic chemotherapy for platinum-resistant ovarian cancer is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating IMP4297 in BRCA1/2 mutation-associated ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors [Phase 1]
Phase 1 dose-finding study evaluating safety, tolerability, and pharmacokinetics of SNB-101 (SN-38) in patients with colorectal, breast, pan…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
A Baylor Research Institute-led clinical trial evaluating DNA methylation as an early-detection marker for high-grade serous ovarian cancer …
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: SLV-154 Treatment of Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for SLV-154 evaluating treatment of metastatic solid tumors. The study is currently recruiting across multiple…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers [Phase 1]
Phase 1 trial evaluating a WT1-targeted immunotherapy in HLA-A*0201+ WT1+ recurrent/metastatic cancers has completed, including colorectal c…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas [Phase 2]
Phase 2 trial of sacituzumab govitecan for recurrent platinum-resistant epithelial ovarian cancer, recurrent epithelial endometrial cancer, …
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: ASA in Prevention of Ovarian Cancer (STICs and STONEs) [Phase 2]
Phase 2 trial evaluating aspirin (acetylsalicylic acid) for prevention of ovarian cancer; status is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition [NA]
A completed clinical trial evaluating sequential electronic health record-based interventions to increase genetic testing for hereditary bre…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/2 study of OC-001 in locally advanced or metastatic cancers has been terminated according to its clinical trials registry listing.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers [Phase 2]
Phase 2 trial evaluating mirvetuximab soravtansine as monotherapy in platinum-sensitive epithelial ovarian cancer, peritoneal cancer, and fa…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors [Phase 1]
Phase 1 study of Felmetatug Vedotin (SGN-B7H4V) in advanced solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy [Phase 2]
Phase 2 clinical trial evaluating Promitil in patients with solid tumors carrying deleterious mutations that progressed after prior therapy …
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Phase 1 Study of [225Ac]-FPI-1434 Injection [Phase 1]
A Phase 1 study of [225Ac]-FPI-1434 injection sponsored by Fusion Pharmaceuticals has been terminated.